{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:54:39Z","timestamp":1789674879035,"version":"4.0.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0118881","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T15:18:08Z","timestamp":1426864688000},"page":"e0118881","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles"],"prefix":"10.1371","volume":"10","author":[{"given":"Kelly L.","family":"Warfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Dye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay B.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Unfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Holtsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Shulenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana L.","family":"Swenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Javad","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,20]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"e1000212","DOI":"10.1371\/journal.ppat.1000212","article-title":"Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda","volume":"4","author":"JS Towner","year":"2008","journal-title":"PLoS Pathog"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00705-010-0814-x","article-title":"Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations","volume":"155","author":"JH Kuhn","year":"2010","journal-title":"Arch Virol"},{"issue":"1","key":"ref3","first-page":"30","article-title":"Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa","volume":"7","author":"Y Allaranga","year":"2010","journal-title":"East Afr J Public Health"},{"issue":"5937","key":"ref4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1126\/science.1172705","article-title":"Discovery of swine as a host for the Reston ebolavirus","volume":"325","author":"RW Barrette","year":"2009","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1086\/514285","article-title":"Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation","volume":"179","author":"P Formenty","year":"1999","journal-title":"J Infect Dis"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrmicro2129","article-title":"Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule","volume":"7","author":"NJ Sullivan","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1084\/jem.20011500","article-title":"Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses","volume":"195","author":"S Bavari","year":"2002","journal-title":"J Exp Med"},{"issue":"26","key":"ref8","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1073\/pnas.2237038100","article-title":"Ebola virus-like particles protect from lethal Ebola virus infection","volume":"100","author":"KL Warfield","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0928-8244(03)00273-6","article-title":"Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein","volume":"40","author":"DL Swenson","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/JVI.76.10.4855-4865.2002","article-title":"Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP","volume":"76","author":"T Noda","year":"2002","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1086\/520612","article-title":"Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents","volume":"196","author":"KL Warfield","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2005.02.015","article-title":"Analysis of Ebola virus and VLP release using an immunocapture assay","volume":"127","author":"G Kallstrom","year":"2005","journal-title":"J Virol Methods"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/157016210791208659","article-title":"Virus-like particles as particulate vaccines","volume":"8","author":"L Buonaguro","year":"2010","journal-title":"Curr HIV Res"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"R Noad","year":"2003","journal-title":"Trends in microbiology"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus","volume":"385","author":"J Naslund","year":"2009","journal-title":"Virology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1093\/infdis\/174.Supplement_1.S88","article-title":"Virus-like particles as a rotavirus subunit vaccine","volume":"174","author":"ME Conner","year":"1996","journal-title":"J Infect Dis"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1521-6616(03)00120-7","article-title":"Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers","volume":"108","author":"CO Tacket","year":"2003","journal-title":"Clin Immunol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1586\/14760584.1.1.101","article-title":"Virus-like particles: a new family of delivery systems","volume":"1","author":"F Boisgerault","year":"2002","journal-title":"Expert Rev Vaccines"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-1-4899-1828-4_61","article-title":"Virus-like particle vaccines for mucosal immunization","volume":"412","author":"MK Estes","year":"1997","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0959-440X(00)00073-7","article-title":"Structures of virus and virus-like particles","volume":"10","author":"JE Johnson","year":"2000","journal-title":"Curr Opin Struct Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"KL Warfield","year":"2007","journal-title":"J Infect Dis"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/14760584.7.4.417","article-title":"Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses","volume":"7","author":"DL Swenson","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","article-title":"Induction of Humoral and CD8+ T Cell Responses Are Required for Protection against Lethal Ebola Virus Infection","volume":"175","author":"KL Warfield","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2006.03.021","article-title":"Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies","volume":"351","author":"L Ye","year":"2006","journal-title":"Virology"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2008.09.020","article-title":"Protection against lethal challenge by Ebola virus-like particles produced in insect cells","volume":"383","author":"Y Sun","year":"2009","journal-title":"Virology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S1082","DOI":"10.1093\/infdis\/jir350","article-title":"Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus","volume":"204","author":"D Falzarano","year":"2011","journal-title":"J Infect Dis"},{"issue":"25\u201326","key":"ref27","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1016\/j.vaccine.2004.01.063","article-title":"Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection","volume":"22","author":"KL Warfield","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.13.4.791-793.1981","article-title":"Plaque assay for Ebola virus","volume":"13","author":"JB Moe","year":"1981","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0020001","article-title":"Gene-Specific Countermeasures Against Ebola Virus Based On Antisense Phosphorodiamidate Morpholino Oligomers","volume":"2","author":"KL Warfield","year":"2006","journal-title":"PLoS Pathogens"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S1053","DOI":"10.1093\/infdis\/jir346","article-title":"Advances in virus-like particle vaccines for filoviruses","volume":"204","author":"KL Warfield","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/CVI.00467-09","article-title":"Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector","volume":"17","author":"WD Pratt","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge","volume":"85","author":"TW Geisbert","year":"2011","journal-title":"J Virol"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"SM Jones","year":"2005","journal-title":"Nat Med"},{"issue":"14","key":"ref34","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus","volume":"83","author":"TW Geisbert","year":"2009","journal-title":"J Virol"},{"issue":"23","key":"ref35","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.vaccine.2004.11.070","article-title":"Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections","volume":"23","author":"DL Swenson","year":"2005","journal-title":"Vaccine"},{"issue":"24","key":"ref36","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1073\/pnas.1316902111","article-title":"Vaccinating captive chimpanzees to save wild chimpanzees","volume":"111","author":"KL Warfield","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/JVI.03361-12","article-title":"Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus","volume":"87","author":"AS Herbert","year":"2013","journal-title":"J Virol"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"e1000904","DOI":"10.1371\/journal.ppat.1000904","article-title":"Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species","volume":"6","author":"LE Hensley","year":"2010","journal-title":"PLoS Pathog"},{"issue":"13","key":"ref39","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"JM Dye","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"ref40","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"GG Olinger Jr.","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"ref41","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1128\/JVI.00173-13","article-title":"Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs","volume":"87","author":"X Qiu","year":"2013","journal-title":"J Virol"},{"issue":"207","key":"ref42","first-page":"207ra143","article-title":"mAbs and Ad-Vectored IFN-alpha therapy rescue ebola-infected nonhuman primates when administered after the detection of viremia and symptoms","volume":"5","author":"X Qiu","year":"2013","journal-title":"Sci Transl Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0118881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T22:17:29Z","timestamp":1598825849000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0118881"}},"subtitle":[],"editor":[{"given":"Jens H.","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0118881","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,20]]}}}